Is the Synthetic Cell about Life?

By Gregory Kaebnick Is the “Synthetic Cell” about Life? A bioethicist explores the soul of Venter’s new life form and of his experiment © 2010 Francesco Francavilla / www.francescofrancavilla.com The announcement that the J. Craig Venter Institute has succeeded (finally) in synthesizing the genome of Mycoplasma mycoides—inserting it into a cell of Mycoplasma capricolum whose genome had been removed, and creating a fully functioning My

Written byGregory Kaebnick
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The announcement that the J. Craig Venter Institute has succeeded (finally) in synthesizing the genome of Mycoplasma mycoides—inserting it into a cell of Mycoplasma capricolum whose genome had been removed, and creating a fully functioning Mycoplasma mycoides—has been heralded as the moment that science finally took the magic out of life. Venter has said that the achievement has changed the definition of life. Bioethicist Art Caplan, a friend of mine, thinks it puts forever to rest the idea that living things are “endowed with some sort of special power, force, or property.” It is conclusive proof that life is nothing more than interacting chemicals.

The achievement is arguably a landmark moment in science, but it’s not a philosophical watershed.

1st cell with synthetic genome

All the news that's fun to print

Is This Life?

First, as many have noted, the technical accomplishment is not quite what the JCVI press release ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies